✕
Login
Register
Back to News
Barclays Maintains Overweight on Centene, Raises Price Target to $63
Benzinga Newsdesk
www.benzinga.com
Positive 83.7%
Neg 0%
Neu 0%
Pos 83.7%
Barclays analyst Andrew Mok maintains Centene (NYSE:
CNC
) with a Overweight and raises the price target from $54 to $63.
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment